OQS
COLL icon

Occudo Quantitative Strategies’s Collegium Pharmaceutical COLL Stock Holding History

Occudo Quantitative Strategies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,228
Closed -$521K – 1020
2023
Q2 		$521K Sell
24,228
-19,097
-44% -$434K 0.05% 542
2023
Q1 		$1.04M Buy
43,325
+31,431
+264% +$834K 0.09% 314
2022
Q4 		$276K Sell
11,894
-13,168
-53% -$266K 0.03% 687
2022
Q3 		$401K Buy
+25,062
New +$442K 0.03% 744

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Occudo Quantitative Strategies's COLL Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Collegium Pharmaceutical (COLL) in Q3 2023, closing a stake of 24,228 shares — an estimated $521K sold.

Occudo Quantitative Strategies first reported a position in COLL in Q3 2022 and held it in 4 quarters. The position peaked at $1.04M in Q1 2023. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Collegium Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,228 Collegium Pharmaceutical shares in Q3 2023, an estimated $521K.
  • Occudo Quantitative Strategies first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Collegium Pharmaceutical position peaked at $1.04M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.